AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $28,655,000 | +1133.5% | 1,893,891 | +511.4% | 1.92% | +826.1% |
| Q2 2022 | $2,323,000 | -17.6% | 309,778 | 0.0% | 0.21% | -43.0% |
| Q1 2022 | $2,819,000 | +29.6% | 309,778 | 0.0% | 0.36% | +18.6% |
| Q4 2021 | $2,175,000 | -38.4% | 309,778 | 0.0% | 0.31% | -49.6% |
| Q3 2021 | $3,532,000 | -28.8% | 309,778 | 0.0% | 0.61% | -43.9% |
| Q2 2021 | $4,959,000 | -30.1% | 309,778 | -22.0% | 1.08% | -41.6% |
| Q1 2021 | $7,094,000 | +18.6% | 396,998 | -10.3% | 1.85% | -5.9% |
| Q4 2020 | $5,982,000 | +14.8% | 442,800 | 0.0% | 1.97% | +66.9% |
| Q3 2020 | $5,211,000 | -20.3% | 442,800 | 0.0% | 1.18% | -20.0% |
| Q2 2020 | $6,536,000 | +27.3% | 442,800 | +16.4% | 1.47% | +51.9% |
| Q1 2020 | $5,136,000 | -74.4% | 380,410 | -54.1% | 0.97% | -36.3% |
| Q4 2019 | $20,052,000 | +29.1% | 829,610 | +2.6% | 1.52% | +57.1% |
| Q3 2019 | $15,537,000 | – | 808,391 | – | 0.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |